1. Home
  2. LXEO vs MHF Comparison

LXEO vs MHF Comparison

Compare LXEO & MHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXEO
  • MHF
  • Stock Information
  • Founded
  • LXEO 2017
  • MHF 1988
  • Country
  • LXEO United States
  • MHF United States
  • Employees
  • LXEO N/A
  • MHF N/A
  • Industry
  • LXEO
  • MHF Finance/Investors Services
  • Sector
  • LXEO
  • MHF Finance
  • Exchange
  • LXEO Nasdaq
  • MHF Nasdaq
  • Market Cap
  • LXEO 140.6M
  • MHF 159.1M
  • IPO Year
  • LXEO 2023
  • MHF N/A
  • Fundamental
  • Price
  • LXEO $4.10
  • MHF $7.44
  • Analyst Decision
  • LXEO Strong Buy
  • MHF
  • Analyst Count
  • LXEO 5
  • MHF 0
  • Target Price
  • LXEO $22.80
  • MHF N/A
  • AVG Volume (30 Days)
  • LXEO 919.4K
  • MHF 57.2K
  • Earning Date
  • LXEO 03-24-2025
  • MHF 01-01-0001
  • Dividend Yield
  • LXEO N/A
  • MHF 4.29%
  • EPS Growth
  • LXEO N/A
  • MHF N/A
  • EPS
  • LXEO N/A
  • MHF N/A
  • Revenue
  • LXEO N/A
  • MHF N/A
  • Revenue This Year
  • LXEO N/A
  • MHF N/A
  • Revenue Next Year
  • LXEO N/A
  • MHF N/A
  • P/E Ratio
  • LXEO N/A
  • MHF N/A
  • Revenue Growth
  • LXEO N/A
  • MHF N/A
  • 52 Week Low
  • LXEO $2.32
  • MHF $5.92
  • 52 Week High
  • LXEO $19.50
  • MHF $6.79
  • Technical
  • Relative Strength Index (RSI)
  • LXEO 57.61
  • MHF 48.30
  • Support Level
  • LXEO $3.75
  • MHF $7.55
  • Resistance Level
  • LXEO $4.59
  • MHF $7.83
  • Average True Range (ATR)
  • LXEO 0.48
  • MHF 0.17
  • MACD
  • LXEO 0.24
  • MHF -0.01
  • Stochastic Oscillator
  • LXEO 76.89
  • MHF 29.09

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.

About MHF Western Asset Municipal High Income Fund Inc.

Western Asset Municipal High Income Fund Inc is a diversified closed-end management investment company. The company's objective is to seek high current income exempt from federal income taxes. It invests predominantly in intermediate and long-term municipal debt securities issued by state and local governments.

Share on Social Networks: